Noor Ahmed Nahid,
GRADUATE AST-G
Department:
Pharmacotherapy & Translational Research
Business Phone:
(352) 871-3296
Business Email:
n.nahid@ufl.edu
Publications
2022
CYP2D6 pharmacogenetics and phenoconversion in personalized medicine.
Expert opinion on drug metabolism & toxicology.
18(11):769-785
[DOI] 10.1080/17425255.2022.2160317.
[PMID] 36597259.
2022
Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study.
Genes.
13(7)
[DOI] 10.3390/genes13071260.
[PMID] 35886043.
2019
Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule.
Biomolecules.
9(1)
[DOI] 10.3390/biom9010034.
[PMID] 30669679.
2018
DPYD*2A and MTHFR C677T predict toxicity and efficacy, respectively, in patients on chemotherapy with 5-fluorouracil for colorectal cancer.
Cancer chemotherapy and pharmacology.
81(1):119-129
[DOI] 10.1007/s00280-017-3478-3.
[PMID] 29134491.
2017
Association of TP53 codon 72 and CDH1 genetic polymorphisms with colorectal cancer risk in Bangladeshi population.
Cancer epidemiology.
49:46-52
[DOI] 10.1016/j.canep.2017.05.005.
[PMID] 28554075.
2017
Genetic variants of SULT1A1 and XRCC1 genes and risk of lung cancer in Bangladeshi population.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
39(11)
[DOI] 10.1177/1010428317729270.
[PMID] 29110586.
2017
Loss of the proprioception and touch sensation channel PIEZO2 in siblings with a progressive form of contractures.
Clinical genetics.
91(3):470-475
[DOI] 10.1111/cge.12850.
[PMID] 27607563.
Grants
Dec 2021
– Nov 2022
Impact of CYP2D6 genotypes and inhibitors on opioid therapy in patients with pain
Role: Principal Investigator
Funding: AMER COL OF CLINICAL PHAR
Contact Details
Phones:
- Business:
- (352) 871-3296
Emails:
- Business:
- n.nahid@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100486
GAINESVILLE FL 32610